Skip to search formSkip to main contentSkip to account menu

gadodiamide

Known as: Gd-DTPA-BMA, Gd-DTPA bis-(methylamide), Gadolinium, (5,8-bis((carboxy-kappaO)methyl)-11-(2-(methylamino)-2-(oxo-kappaO)ethyl)-3-(oxo-kappaO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kappaN5,kappaN8,kappaN11,kappaO13)- 
A paramagnetic gadolinium-based contrast agent (GBCA), with imaging activity upon magnetic resonance imaging (MRI). When placed in a magnetic field… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Objectives The purpose of this preclinical study was to investigate whether moderate chronic kidney disease is a factor in… 
2010
2010
The bulk monomer, butyl methacrylate (BMA), was copolymerized with an ionizable monomer (mono‐(2‐(methacryloyloxy)ethyl… 
Highly Cited
2000
Highly Cited
2000
Gadolinium is used as a relaxation agent in magnetic resonance imaging (MRI) because of its large paramagnetic moment, high water… 
2000
2000
RATIONALE AND OBJECTIVES To demonstrate that gadodiamide injection is a safe and efficient contrast agent for MRI in infants… 
1998
1998
Abstract. Our objective was: (1) to determine the appropriate dose of new ultrasmall superparamagnetic iron oxide particles for… 
1997
1997
Formation of ternary complexes between Gd‐DTPA, Gd‐DTPA‐BMA, and Gd‐DOTA, used as contrast enhancement agents in MRI and the…